Anebulo Pharmaceuticals
ANEB
ANEB
10 hedge funds and large institutions have $29.5M invested in Anebulo Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$60.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5K |
Top Sellers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$55.5K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$36.6K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3K |
| 4 |
BlackRock
New York
|
-$2.56K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $23.8M | – | – | – |
|
|
MP
2
Mangrove Partners
Greenwich,
Connecticut
| $2.83M | -$55.5K | -7,840 | -2% |
|
|
LCM
3
Laurion Capital Management
New York
| $1.48M | -$36.6K | -5,417 | -2% |
|
|
IC
4
Ikarian Capital
Dallas,
Texas
| $1.23M | +$60.1K | +8,890 | +5% |
|
|
BFM
5
Boothbay Fund Management
New York
| $123K | – | – | – |
|
|
6
BlackRock
New York
| $53K | -$2.56K | -360 | -5% |
|
|
7
UBS Group
Zurich,
Switzerland
| $15K | +$11K | +1,576 | +272% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $5K | +$5K | +756 | New |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| – | -$3K | -500 | Closed |
|